Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.345
-0.125 (-8.50%)
Oct 26, 2026, 2:30 PM EDT - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $228.04 million as of October 26, 2026. It is the 19,312th most valuable company in the world and the 3,377th biggest in the United States. Its market cap has increased by 0.94% in one year.
Market Cap
228.04M
Enterprise Value
28.65M
1-Year Change
0.94%
Global Rank
Country Rank
#3,377 United States
Category
ChartMarket Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $228.04M, a decrease of -3.18%. That is a compound annual growth rate of -0.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 228.04M | 8.17% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 240.67M |
| Greenwich LifeSciences | 238.81M |
| Vogenx | 237.38M |
| Larimar Therapeutics | 234.86M |
| InflaRx | 234.32M |
| Sol-Gel Technologies | 234.09M |
| AC Immune | 230.17M |
| Keros Therapeutics | 225.63M |